KBC Group NV - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 113 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
KBC Group NV ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$205,000
+65.3%
164,068
+69.4%
0.00%0.0%
Q3 2019$124,000
-56.3%
96,856
+17.7%
0.00%
-50.0%
Q2 2019$284,000
-69.3%
82,286
-54.8%
0.00%
-75.0%
Q1 2019$924,000
+34.9%
182,221
-3.9%
0.01%0.0%
Q4 2018$685,000
-49.4%
189,617
-17.7%
0.01%
-20.0%
Q3 2018$1,355,000230,3650.01%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders